No new classes of antibiotics has been discovered since 1987. They are looked upon as a poor investment by pharmaceutical entrepreneurs because there are so many generic competitors. To make it even more complicated, any new antibiotic that might be invented would have to be held in reserve for a major case of an antibiotic resistant infection.

Recent Comments